Brian I. Rini : rechercher sur Z-Library

Campagne de collecte 15 septembre 2024 – 1 octobre 2024 C'est quoi, la collecte de fonds?

Le plus grand référentiel d'articles scientifiques au monde. 70,000,000+ d'articles gratuitement.

Campagne de collecte 15 septembre 2024 – 1 octobre 2024

Z-Library est une des plus grandes bibliothèques en ligne dans le monde, avec le stockage de plus de 17,000,000 livres et plus de 84,837,000 articles. Nous encourageons l'accès libre de chacun à la littérature. Aujourd'hui (15 septembre 2024) nous faisons un appel de fonds à tous ceux qui veulent contribuer encore plus au soutien et au développement de notre projet.

Les téléchargements SANS LIMITE sont aussi (au cours de 31 jours après la date de don) disponibles pour TOUS les utilisateurs qui soient en mesure de soutenir le projet pendant la période de collecte de fonds jusqu'au 1 octobre 2024.

C'est quoi, la collecte de fonds?En savoir plus

Livres
Articles (331)
Les plus populaires
Liste
- Liste
- Tableau

1

Spray Cooling of IGBT Devices

Mertens, Robert G., Chow, Louis, Sundaram, Kalpathy B., Cregger, R. Brian, Rini, Daniel P., Turek, Louis, Saarloos, Benjamin A.

Journal:

Journal of Electronic Packaging

Année:

2007

Langue:

english

Fichier:

PDF, 303 KB

english, 2007

2

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Rini, Brian I., Plimack, Elizabeth R., Stus, Viktor, Gafanov, Rustem, Hawkins, Robert, Nosov, Dmitry, Pouliot, Frédéric, Alekseev, Boris, Soulières, Denis, Melichar, Bohuslav, Vynnychenko, Ihor, Kryzh

Journal:

New England Journal of Medicine

Année:

2019

Langue:

english

Fichier:

PDF, 298 KB

english, 2019

3

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial

Brian I Rini, Bernard Escudier, Piotr Tomczak, Andrey Kaprin, Cezary Szczylik, Thomas E Hutson, M Dror Michaelson, Vera A Gorbunova, Martin E Gore, Igor G Rusakov, Sylvie Negrier, Yen-Chuan Ou, Daniel

Journal:

Année:

2011

Langue:

english

Fichier:

PDF, 363 KB

english, 2011

4

Angiogenesis and the Tumor Microenvironment: Vascular Endothelial Growth Factor and Beyond

Mittal, Kriti, Ebos, John, Rini, Brian

Journal:

Seminars in Oncology

Année:

2014

Langue:

english

Fichier:

PDF, 392 KB

english, 2014

5

Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Motzer, Robert J., Penkov, Konstantin, Haanen, John, Rini, Brian, Albiges, Laurence, Campbell, Matthew T., Venugopal, Balaji, Kollmannsberger, Christian, Negrier, Sylvie, Uemura, Motohide, Lee, Jae L.

Journal:

New England Journal of Medicine

Année:

2019

Langue:

english

Fichier:

PDF, 333 KB

english, 2019

6

Optimizing treatment of renal cell carcinoma with VEGFR-TKIs: a comparison of clinical pharmacology and drug-drug interactions of anti-angiogenic drugs

Fogli, Stefano, Porta, Camillo, Del Re, Marzia, Crucitta, Stefania, Gianfilippo, Giulia, Danesi, Romano, Rini, Brian I., Schmidinger, Manuela

Journal:

Cancer Treatment Reviews

Année:

2020

Langue:

english

Fichier:

PDF, 1007 KB

english, 2020

7

A Phase I trial of fixed dose rate gemcitabine and capecitabine in metastatic renal cell carcinoma

Brian I. Rini, Vivian Weinberg, Eric J. Small

Journal:

Année:

2005

Langue:

english

Fichier:

PDF, 82 KB

english, 2005

8

Combination immunotherapy with prostatic acid phosphatase pulsed antigen-presenting cells (provenge) plus bevacizumab in patients with serologic progression of prostate cancer after definitive local therapy

Brian I. Rini, Vivian Weinberg, Lawrence Fong, Shauna Conry, Robert M. Hershberg, Eric J. Small

Journal:

Année:

2006

Langue:

english

Fichier:

PDF, 125 KB

english, 2006

9

Pericyte coverage of differentiated vessels inside tumor vasculature is an independent unfavorable prognostic factor for patients with clear cell renal cell carcinoma

Yun Cao, Zhi-Ling Zhang, Ming Zhou, Paul Elson, Brian Rini, Hakan Aydin, Kristin Feenstra, Min-Han Tan, Bree Berghuis, Rebeka Tabbey, James H. Resau, Fang-Jian Zhou, Bin Tean Teh, Chao-Nan Qian

Journal:

Année:

2012

Langue:

english

Fichier:

PDF, 1.55 MB

english, 2012

10

Clinical Outcome in Metastatic Renal Cell Carcinoma Patients After Failure of Initial Vascular Endothelial Growth Factor-Targeted Therapy

Michael M. Vickers, Toni K. Choueiri, Miranda Rogers, Andrew Percy, Daygen Finch, Ivan Zama, Tina Cheng, Scott North, Jennifer J. Knox, Christian Kollmannsberger, David F. McDermott, Brian I. Rini, Da

Journal:

Année:

2010

Langue:

english

Fichier:

PDF, 190 KB

english, 2010

11

Resistance to targeted therapy in renal-cell carcinoma

Brian I Rini, Michael B Atkins

Journal:

The Lancet Oncology

Année:

2009

Langue:

english

Fichier:

PDF, 1002 KB

english, 2009

12

Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study

Olivier Rixe, Ronald M Bukowski, M Dror Michaelson, George Wilding, Gary R Hudes, Oliver Bolte, Robert J Motzer, Paul Bycott, Katherine F Liau, James Freddo, Peter C Trask, Sinil Kim, Brian I Rini

Journal:

The Lancet Oncology

Année:

2007

Langue:

english

Fichier:

PDF, 143 KB

english, 2007

13

Renal Cell Carcinoma || C-MET as a Novel Target for the Treatment of Renal Cell Carcinoma

Figlin, Robert A., Rathmell, W. Kimryn, Rini, Brian I.

Année:

2012

Langue:

english

Fichier:

PDF, 398 KB

english, 2012

14

A Phase II Study of Pazopanib in Patients with Localized Renal Cell Carcinoma to Optimize Preservation of Renal Parenchyma

Rini, Brian I., Plimack, Elizabeth R., Takagi, Toshio, Elson, Paul, Wood, Laura S., Dreicer, Robert, Gilligan, Timothy, Garcia, Jorge, Zhang, Zhiling, Kaouk, Jihad, Krishnamurthi, Venkatesh, Stephenso

Journal:

The Journal of Urology

Année:

2015

Langue:

english

Fichier:

PDF, 1.01 MB

english, 2015

15

Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma

Choueiri, Toni K., Escudier, Bernard, Powles, Thomas, Mainwaring, Paul N., Rini, Brian I., Donskov, Frede, Hammers, Hans, Hutson, Thomas E., Lee, Jae-Lyun, Peltola, Katriina, Roth, Bruce J., Bjarnason

Journal:

New England Journal of Medicine

Année:

2015

Langue:

english

Fichier:

PDF, 573 KB

english, 2015

16

The safety and efficacy of nivolumab for the treatment of advanced renal cell carcinoma

Ornstein, Moshe C., Rini, Brian I.

Journal:

Expert Review of Anticancer Therapy

Année:

2016

Langue:

english

Fichier:

PDF, 556 KB

english, 2016

17

Neoadjuvant therapy for localized and locally advanced renal cell carcinoma

Bindayi, Ahmet, Hamilton, Zachary A., McDonald, Michelle L., Yim, Kendrick, Millard, Frederick, McKay, Rana R., Campbell, Steven C., Rini, Brian I., Derweesh, Ithaar H.

Journal:

Urologic Oncology: Seminars and Original Investigations

Année:

2017

Langue:

english

Fichier:

PDF, 427 KB

english, 2017

18

Imaging strategy and outcome following partial nephrectomy

Mouracade, Pascal, Chavali, Jaya S., Kara, Onder, Dagenais, Julien, Maurice, Matthew J., Nelson, Ryan J., Rini, Brian I., Kaouk, Jihad H.

Journal:

Urologic Oncology: Seminars and Original Investigations

Année:

2017

Langue:

english

Fichier:

PDF, 227 KB

english, 2017

19

Emerging Immunotherapy in Advanced Renal Cell Carcinoma

Mendiratta, Prateek, Rini, Brian I., Ornstein, Moshe C.

Journal:

Urologic Oncology: Seminars and Original Investigations

Année:

2017

Langue:

english

Fichier:

PDF, 280 KB

english, 2017

20

Patient Characteristics, Treatment Patterns and Prognostic Factors in Squamous Cell Bladder Cancer

Zahoor, Haris, Elson, Paul, Stephenson, Andrew, Haber, Georges-Pascal, Kaouk, Jihad, Fergany, Amr, Lee, Byron, Koshkin, Vadim, Ornstein, Moshe, Gilligan, Timothy, Garcia, Jorge A., Rini, Brian, Grivas

Journal:

Clinical Genitourinary Cancer

Année:

2017

Langue:

english

Fichier:

PDF, 448 KB

english, 2017

21

Treatment selection for men with metastatic prostate cancer who progress on upfront chemo-hormonal therapy

Barata, Pedro, Emamekhoo, Hamid, Mendiratta, Prateek, Koshkin, Vadim, Tyler, Allison, Ornstein, Moshe, Rini, Brian I., Gilligan, Timothy, Kyriakopoulos, Christos, Gracia, Jorge A.

Journal:

Année:

2018

Langue:

english

Fichier:

PDF, 434 KB

english, 2018

22

The association between facility case volume and overall survival in patients with metastatic renal cell carcinoma in the targeted therapy era

Chen, Yu-Wei, Ornstein, Moshe C., Wood, Laura S., Allman, Kimberly D., Martin, Allison, Beach, Jennifer, Gilligan, Timothy, Garcia, Jorge A., Rini, Brian I.

Journal:

Urologic Oncology: Seminars and Original Investigations

Année:

2018

Langue:

english

Fichier:

PDF, 710 KB

english, 2018

23

Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial

Rini, Brian I, Powles, Thomas, Atkins, Michael B, Escudier, Bernard, McDermott, David F, Suarez, Cristina, Bracarda, Sergio, Stadler, Walter M, Donskov, Frede, Lee, Jae Lyun, Hawkins, Robert, Ravaud,

Journal:

Lancet (London, England)

Année:

2019

Langue:

english

Fichier:

PDF, 646 KB

english, 2019

24

Efficacy of Nivolumab plus Ipilimumab According to Number of IMDC Risk Factors in CheckMate 214

Escudier, Bernard, Motzer, Robert J., Tannir, Nizar M., Porta, Camillo, Tomita, Yoshihiko, Maurer, Matthew A., McHenry, M. Brent, Rini, Brian I.

Journal:

European Urology

Année:

2019

Langue:

english

Fichier:

PDF, 993 KB

english, 2019

25

Patient-reported outcomes in a phase 2 study comparing atezolizumab alone or with bevacizumab vs sunitinib in previously untreated metastatic renal cell carcinoma

Pal, Sumanta K., McDermott, David F., Atkins, Michael B., Escudier, Bernard, Rini, Brian I., Motzer, Robert J., Fong, Lawrence, Joseph, Richard W., Oudard, Stephane, Ravaud, Alain, Bracarda, Sergio, S

Journal:

BJU International

Année:

2020

Fichier:

PDF, 10.34 MB

2020

26

The COVID-19 & Cancer Consortium (CCC19): a collaborative effort to understand the effects of COVID-19 on patients with cancer

Rubinstein, Samuel, Steinharter, John A., Warner, Jeremy, Rini, Brian I., Peters, Solange, Choueiri, Toni K.

Journal:

Année:

2020

Fichier:

PDF, 1.08 MB

2020

27

Systemic therapy for advanced clear cell renal cell carcinoma after discontinuation of immune-oncology and VEGF targeted therapy combinations

Ged, Yasser, Gupta, Ruby, Duzgol, Cihan, Knezevic, Andrea, Shapnik, Natalie, Kotecha, Ritesh, Voss, Martin H., Feldman, Darren R., Akin, Oguz, Patil, Sujata, Motzer, Robert J., Rini, Brian I., Lee, Ch

Journal:

Année:

2020

Fichier:

PDF, 826 KB

2020

28

Granulocyte-macrophage-colony stimulating factor in metastatic renal cell carcinoma : A phase II trial

Brian I. Rini, Walter M. Stadler, Ricardo T. Spielberger, Mark J. Ratain, Nicholas J. Vogelzang

Journal:

Année:

1998

Langue:

english

Fichier:

PDF, 87 KB

english, 1998

29

A high rate of venous thromboembolism in a multi-institutional Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil and daily thalidomide in patients with metastatic renal cell carcinoma

Apurva A. Desai, Nicholas J. Vogelzang, Brian I. Rini, Rafat Ansari, Stuart Krauss, Walter M. Stadler

Journal:

Année:

2002

Langue:

english

Fichier:

PDF, 87 KB

english, 2002

30

Time to disease progression to evaluate a novel protein kinase C inhibitor, UCN-01, in renal cell carcinoma

Brian I. Rini, Vivian Weinberg, Vanessa Shaw, Janet Scott, Robert Bok, John W. Park, Eric J. Small

Journal:

Année:

2004

Langue:

english

Fichier:

PDF, 80 KB

english, 2004

31

Maximal COX-2 immunostaining and clinical response to celecoxib and interferon alpha therapy in metastatic renal cell carcinoma

Brian I. Rini, Vivian Weinberg, Sarah Dunlap, Alexandra Elchinoff, Nancy Yu, Robert Bok, Jeffery Simko, Eric J. Small

Journal:

Année:

2006

Langue:

english

Fichier:

PDF, 250 KB

english, 2006

32

A phase II study of gemcitabine and capecitabine in metastatic renal cancer : A report of Cancer and Leukemia Group B protocol 90008

Walter M. Stadler, Susan Halabi, Brian Rini, Marc S. Ernstoff, Enrique Davila, Joel Picus, Robert Barrier, Eric J. Small, for Cancer, Leukemia Group B

Journal:

Année:

2006

Langue:

english

Fichier:

PDF, 100 KB

english, 2006

33

Phase II study of lenalidomide in patients with metastatic renal cell carcinoma

Toni K. Choueiri, Robert Dreicer, Brian I. Rini, Paul Elson, Jorge A. Garcia, Snehal G. Thakkar, Rachid C. Baz, Tarek M. Mekhail, Holly A. Jinks, Ronald M. Bukowski

Journal:

Année:

2006

Langue:

english

Fichier:

PDF, 438 KB

english, 2006

34

Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy

Toni K. Choueiri, Jorge A. Garcia, Paul Elson, Mohamad Khasawneh, Saif Usman, Ali Reza Golshayan, Rachid C. Baz, Laura Wood, Brian I. Rini, Ronald M. Bukowski

Journal:

Année:

2007

Langue:

english

Fichier:

PDF, 124 KB

english, 2007

35

Differential expression of caveolin-1 in renal neoplasms

Ila Tamaskar, Toni K. Choueiri, Linda Sercia, Brian Rini, Ronald Bukowski, Ming Zhou

Journal:

Année:

2007

Langue:

english

Fichier:

PDF, 375 KB

english, 2007

36

Sunitinib-induced macrocytosis in patients with metastatic renal cell carcinoma

Brian I. Rini, Toni K. Choueiri, Paul Elson, Mohamad K. Khasawneh, Claudiu Cotta, Jaya Unnithan, Laura Wood, Tarek Mekhail, Jorge Garcia, Robert Dreicer, Ronald M. Bukowski

Journal:

Année:

2008

Langue:

english

Fichier:

PDF, 175 KB

english, 2008

37

A population-based study evaluating the impact of sunitinib on overall survival in the treatment of patients with metastatic renal cell cancer

Daniel Y. C. Heng, Kim N Chi, Nevin Murray, Tao Jin, Jorge A Garcia, Ronald M Bukowski, Brian I Rini, Christian Kollmannsberger

Journal:

Année:

2009

Langue:

english

Fichier:

PDF, 183 KB

english, 2009

38

Innovations and challenges in renal cancer: Summary statement from the Third Cambridge Conference

Michael B. Atkins, Ronald M. Bukowski, Bernard J. Escudier, Robert A. Figlin, Gary H. Hudes, William G. Kaelin Jr, W. Marston Linehan, David F. McDermott, James W. Mier, Ivan Pedrosa, Brian I. Rini, S

Journal:

Année:

2009

Langue:

english

Fichier:

PDF, 104 KB

english, 2009

39

Vascular endothelial growth factor-targeted therapy in metastatic renal cell carcinoma

Journal:

Année:

2009

Langue:

english

Fichier:

PDF, 276 KB

english, 2009

40

Sorafenib in patients with metastatic renal cell carcinoma refractory to either sunitinib or bevacizumab

Jorge A. Garcia, Thomas E. Hutson, Paul Elson, C. Lance Cowey, Timothy Gilligan, Cheryl Nemec, Robert Dreicer, Ronald M. Bukowski, Brian I. Rini

Journal:

Année:

2010

Langue:

english

Fichier:

PDF, 249 KB

english, 2010

41

Sunitinib rechallenge in metastatic renal cell carcinoma patients

Ivan N. Zama, Thomas E. Hutson, Paul Elson, James M. Cleary, Toni K. Choueiri, Daniel Y.C. Heng, Nikhil Ramaiya, M. Dror Michaelson, Jorge A. Garcia, Jennifer J. Knox, Bernard Escudier, Brian I. Rini

Journal:

Année:

2010

Langue:

english

Fichier:

PDF, 278 KB

english, 2010

42

Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma

Brian I. Rini, Mark Stein, Pat Shannon, Simantini Eddy, Allison Tyler, Joe J. Stephenson Jr, Lorie Catlett, Bo Huang, Diane Healey, Michael Gordon

Journal:

Année:

2011

Langue:

english

Fichier:

PDF, 273 KB

english, 2011

43

The impact of tumor burden characteristics in patients with metastatic renal cell carcinoma treated with sunitinib

Naveen S. Basappa, Paul Elson, Ali-Reza Golshayan, Laura Wood, Jorge A. Garcia, Robert Dreicer, Brian I. Rini

Journal:

Année:

2011

Langue:

english

Fichier:

PDF, 224 KB

english, 2011

44

Progression-free survival as a predictor of overall survival in metastatic renal cell carcinoma treated with contemporary targeted therapy

Daniel Y. C. Heng, Wanling Xie, Georg A. Bjarnason, Ulka Vaishampayan, Min-Han Tan, Jennifer Knox, Frede Donskov, Lori Wood, Christian Kollmannsberger, Brian I. Rini, Toni K. Choueiri

Journal:

Année:

2011

Langue:

english

Fichier:

PDF, 238 KB

english, 2011

45

The impact of kidney function on the outcome of metastatic renal cell carcinoma patients treated with vascular endothelial growth factor-targeted therapy

Robyn Macfarlane, Daniel Y. C. Heng, Wanling Xie, Jennifer J. Knox, David F. McDermott, Brian I. Rini, Christian Kollmannsberger, Toni K. Choueiri

Journal:

Année:

2012

Langue:

english

Fichier:

PDF, 130 KB

english, 2012

46

Determining the optimal dose and schedule of sunitinib : Some Answers, More Questions

Cristina Suarez, Brian I. Rini

Journal:

Année:

2012

Langue:

english

Fichier:

PDF, 720 KB

english, 2012

47

Germline and somatic DNA methylation and epigenetic regulation of KILLIN in renal cell carcinoma

Kristi L. Bennett, Rebecca Campbell, Shireen Ganapathi, Ming Zhou, Brian Rini, Ram Ganapathi, Hartmut P.H. Neumann, Charis Eng

Journal:

Genes, Chromosomes and Cancer

Année:

2011

Langue:

english

Fichier:

PDF, 476 KB

english, 2011

48

Sunitinib facilitates the activation and recruitment of therapeutic anti-tumor immunity in concert with specific vaccination

Anamika Bose, Jennifer L. Taylor, Sean Alber, Simon C. Watkins, Jorge A. Garcia, Brian I. Rini, Jennifer S. Ko, Peter A. Cohen, James H. Finke, Walter J. Storkus

Journal:

International Journal of Cancer

Année:

2011

Langue:

english

Fichier:

PDF, 1.23 MB

english, 2011

49

The potential for prostate cancer immunotherapy

Brian I. Rini, Eric J Small

Journal:

Critical Reviews in Oncology/Hematology

Année:

2003

Langue:

english

Fichier:

PDF, 264 KB

english, 2003

50

The HLA-A2-restricted PSMA peptide LLHETDSAV is poorly immunogenic in patients with metastatic prostate cancer

David Knight, Amy C. Peterson, Brian I. Rini, Helena Harlin, Thomas F. Gajewski, Walter M. Stadler

Journal:

Année:

2009

Langue:

english

Fichier:

PDF, 114 KB

english, 2009